Legal & General Group Plc - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,543
-24.0%
5,0660.0%0.00%
Q4 2022$5,978
-84.3%
5,0660.0%0.00%
Q3 2022$38,000
+40.7%
5,066
+17.1%
0.00%
Q2 2022$27,000
+22.7%
4,327
+62.0%
0.00%
Q1 2022$22,000
+57.1%
2,6710.0%0.00%
Q4 2021$14,000
-22.2%
2,6710.0%0.00%
Q3 2021$18,000
-21.7%
2,6710.0%0.00%
Q2 2021$23,000
-25.8%
2,671
-24.3%
0.00%
Q1 2021$31,000
-31.1%
3,528
-3.8%
0.00%
Q4 2020$45,000
+66.7%
3,669
+10.4%
0.00%
Q3 2020$27,000
-28.9%
3,322
-16.1%
0.00%
Q2 2020$38,000
+40.7%
3,959
-0.9%
0.00%
Q1 2020$27,000
-62.5%
3,993
-17.2%
0.00%
Q4 2019$72,000
+80.0%
4,822
+23.3%
0.00%
Q3 2019$40,000
-2.4%
3,9120.0%0.00%
Q2 2019$41,000
+310.0%
3,912
+327.5%
0.00%
Q1 2017$10,0000.0%9150.0%0.00%
Q4 2016$10,0009150.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders